Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDORMS have been successful with 3 Clinical Trials (BioPatch, MANTIS and NINJA) being awarded.

BioPatch

NIHR i4i committee has approved Prof Andrew Carr’s application entitled “A novel electrospun patch to augment rotator cuff tendon repair” - Oxford BioPatch. The Oxford Biopatch is an innovative solution for rotator cuff repair which promotes rapid regrowth of tendon tissue and could transform the success of shoulder repair operations. Speaking about the award Prof Carr stated that “The monies from the NIHR are invaluable to investigate whether a nanofiber surgical patch invented in Oxford can improve the outcome of surgery for tendon repair in the shoulder and we are looking forward to discovering if the technology can improve patient recovery”.

MANTIS

NIHR HTA committee has approved Prof Sion Glyn-Jones application entitled “Managing Avascular Necrosis Treatments: An Interventional Study” MANTIS. This will be looking at the debilitating affect that Avascular Necrosis (AVN) of the hip occurs in younger people and how this may be managed by an effective drug treatment. Lead Researcher Prof Sion Glyn Jones states that “With this support from NIHR we have the opportunity to find an effective drug treatment for this condition could improve the quality of life for thousands of young people”

NINJA

NIHR RfPB committee has approved Prof Abhilash Jain and his application entitled “Nail Injury Analysis Trial” NINJA. This will be looking into childrens’ fingertip injuries which is the most common surgically treated paediatric hand injury with 10,000 operations performed every year in the UK. Despite this there are no published randomized controlled trials (RCT) looking at surgical interventions and NINJA is the first multi-centre RCT looking at ways to improve surgical outcomes in these patients. On receiving confirmation of the award Prof Jain stated “This award from NIHR will allow us to evaluate two differing repair techniques with the intention of advising best practice to clinicians for future Injuries”.

Our Team

Further Information on the Trials

Similar stories

Matthew Costa elected Fellow of Academy of Medical Sciences

Matthew Costa, Professor of Orthopaedic Trauma Surgery at NDORMS, has been elected a Fellow of the Academy of Medical Sciences.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

REF 2021 results for medical research in Oxford

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Nurses' Day 2022

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

Rethinking pain management after injury

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.